Clearmind Medicine Inc. Finance Costs
Clearmind Medicine Inc. (CMND) reported Finance Costs of $411.10 thousand for the 3-month period ending 2023-04-30, per its 6-K filed 2023-06-14.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2023-06-14
- Clearmind Medicine Inc. finance costs for the quarter ending 2023-01-31 was 5.00K CAD, a 22.63% decline year-over-year.
- Clearmind Medicine Inc. finance costs for the quarter ending 2022-01-31 was 6.46K CAD.
CAD
| Period end | Finance Costs 0 month | Finance Costs 3 month | Finance Costs 12 month |
|---|---|---|---|
| 2023-01-31 | 5.00K CAD 6-K · filed 2023-03-17 | ||
| 2022-10-31 | 837.47K CAD 20-F · filed 2023-02-06 | ||
| 2022-01-31 | 6.46K CAD 6-K · filed 2023-03-17 | ||
| 2021-10-31 | 33.53K CAD 20-F · filed 2023-02-06 | ||
| 2020-03-12 | 51.30K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Finance Costs 3 month | Finance Costs 6 month |
|---|---|---|
| 2023-04-30 | $411.10K 6-K · filed 2023-06-14 | $490.68K 6-K · filed 2023-06-14 |
| 2022-04-30 | $105.15K 6-K · filed 2023-06-14 | $109.88K 6-K · filed 2023-06-14 |